Pulse Biosciences (PLSE) Return on Capital Employed (2016 - 2026)
Pulse Biosciences (PLSE) posted quarterly Return on Capital Employed of 75.33% for Q3 2025, up 556.0% year-over-year from 11.48% in Q3 2024, and down 22.88% quarter-over-quarter from 61.3% in Q2 2025.
Pulse Biosciences (PLSE) Return on Capital Employed (2016 - 2026) Analysis & Trends
Pulse Biosciences' Return on Capital Employed history runs 10 years deep, the most recent figure standing at 75.33% for Q3 2025.
- In Q3 2025, Return on Capital Employed rose 556.0% year-over-year to 75.33%; the TTM figure through Sep 2025 stood at 75.33% (up 556.0% YoY), while the FY2025 annual figure was 183.8%, up 24940.0% from the prior year.
- Return on Capital Employed for Q3 2025 stood at 75.33%, down from 61.3% in the prior quarter.
- The five-year high for Return on Capital Employed was 50.88% in Q1 2025, with the low at 187.59% in Q2 2022.
- The 5-year median for Return on Capital Employed is 80.89% (2024), against an average of 92.18%.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed slumped 10244 bps in 2022, then soared 11797 bps in 2023.
- Pulse Biosciences' Return on Capital Employed stood at 111.64% in 2021, then surged by 32 bps to 75.65% in 2022, then fell by 3 bps to 78.03% in 2023, then advanced by 30 bps to 54.78% in 2024, then tumbled by 38 bps to 75.33% in 2025.
- Business Quant data shows PLSE's Return on Capital Employed at 75.33% in Q3 2025, 61.3% in Q2 2025, and 50.88% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | -89.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -89.25% |
| Sep 30, 2025 | -75.33% |
| Jun 30, 2025 | -61.30% |
| Mar 31, 2025 | -50.88% |
| Dec 31, 2024 | -54.78% |
| Sep 30, 2024 | -80.89% |
| Jun 30, 2024 | -118.78% |
| Mar 31, 2024 | -90.93% |
| Dec 31, 2023 | -78.03% |
| Sep 30, 2023 | -61.29% |
| Jun 30, 2023 | -69.62% |
| Mar 31, 2023 | -75.08% |
| Dec 31, 2022 | -75.65% |
| Sep 30, 2022 | -113.38% |
| Jun 30, 2022 | -187.59% |
| Mar 31, 2022 | -152.73% |
| Dec 31, 2021 | -111.64% |
| Sep 30, 2021 | -95.76% |
| Jun 30, 2021 | -85.15% |
| Mar 31, 2021 | -112.55% |